Thrive Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,206
| Closed | -$437K | – | 210 |
|
|
2024
Q3 | $437K | Sell |
5,206
-1,788
| -26% | -$150K | 0.08% | 128 |
|
|
2024
Q2 | $480K | Buy |
6,994
+1,119
| +19% | +$76.8K | 0.09% | 107 |
|
|
2024
Q1 | $430K | Sell |
5,875
-1,900
| -24% | -$139K | 0.09% | 119 |
|
|
2023
Q4 | $630K | Buy |
7,775
+594
| +8% | +$48.1K | 0.14% | 91 |
|
|
2023
Q3 | $538K | Buy |
7,181
+157
| +2% | +$11.8K | 0.14% | 93 |
|
|
2023
Q2 | $541K | Sell |
7,024
-45
| -0.6% | -$3.47K | 0.14% | 92 |
|
|
2023
Q1 | $587K | Buy |
7,069
+883
| +14% | +$73.3K | 0.15% | 84 |
|
|
2022
Q4 | $531K | Buy |
6,186
+93
| +2% | +$7.98K | 0.15% | 86 |
|
|
2022
Q3 | $376K | Buy |
6,093
+1,301
| +27% | +$80.3K | 0.13% | 98 |
|
|
2022
Q2 | $296K | Buy |
+4,792
| New | +$296K | 0.1% | 122 |
|
|
2022
Q1 | – | Sell |
-4,907
| Closed | -$356K | – | 157 |
|
|
2021
Q4 | $356K | Buy |
+4,907
| New | +$356K | 0.12% | 109 |
|